A scientific symposium dedicated to the preclinical studies of multiple sclerosis (MS) is scheduled to take place in Tehran. The event is jointly organized by the Royan Institute and the Multiple Sclerosis Research Center of Sina Hospital, which is affiliated with the Tehran University of Medical Sciences. The symposium will be held on December 31st in Tehran under the title 'Preclinical Studies of Multiple Sclerosis.'
It will gather physicians and researchers to discuss new experimental models, methodological advancements, and translational research strategies aimed at improving the understanding and treatment of this disease.
The event will be held at the Multiple Sclerosis Research Center of Sina Hospital to commemorate the anniversary of the death of Dr. Said Kazemi Ashtiani, the founder of the Royan Institute. Furthermore, it aims to honor his scientific legacy by strengthening cooperation and academic exchange between scientists and clinicians.
Scientific Supervisors and Organizers
The scientific supervisors of the symposium will be Dr. Mohammad Javan from the Royan Institute and Tarbiat Modares University, and Dr. Sajad Sahabnegah from the Multiple Sclerosis Research Center of Sina Hospital. Dr. Alireza Alizadeh Moghadam Masoleh will serve as the course director and executive secretary from the Royan Institute.
Preclinical studies are a critically important stage in the development of therapeutic interventions and drugs. They are conducted before clinical trials in humans and help assess the safety and efficacy of potential treatments, as well as the reproducibility of the results obtained. Rigorous preclinical studies contribute to improving the quality of subsequent clinical investigations, reducing risks, and optimizing the use of financial and human resources.
Given the complex nature of MS and the need for a deeper understanding of its onset and progression mechanisms, reliable preclinical approaches are of particular importance. These methods increasingly incorporate interdisciplinary approaches and the integration of computational, cellular, and animal models to study the pathogenesis of the disease and evaluate possible therapeutic methods.
Scientific Scope and Main Topics
The symposium will cover various scientific and methodological issues, including the relationship between preclinical and clinical MS studies, future research directions, the etiology of the disease, myelin repair and remyelination, basic principles of preclinical drug design, and medical chemistry.
Special attention will be paid to computational models and in vitro experimental methods that can reduce dependence on laboratory animals. The spectrum of strengths and weaknesses of various animal models, such as mice, rats, and zebrafish, as well as statistical aspects in planning and analyzing preclinical work, will also be studied.
New Research Opportunity
One of the key highlights will be the presentation of a multiple sclerosis model based on zebrafish, developed in the Royan Institute's zebrafish Laboratory. This model may open up additional opportunities to study disease-related mechanisms and evaluate potential therapeutic approaches.
The presentation will also showcase the results of joint research between the Royan Institute and the Multiple Sclerosis Research Center of Sina Hospital, focusing on developing approaches to studying MS using zebrafish. This initiative was conducted under the scientific guidance of Dr. Mohammad Ali Sahrayan and Dr. Hossein Baharvandan.
In addition to the symposium, a three-day practical workshop titled 'Introduction to Zebrafish and Its Application in Human Disease Modeling' will be held from January 6 to 8, 2027, at the Royan Institute's Central Zebrafish Laboratory in Tehran, with a special focus on multiple sclerosis. The workshop will provide participants with hands-on experience in zebrafish research methods and their application in human disease modeling.



